May 20, 2008 - There were no device-related events at 30 days follow-up of the first 13 patients in the OPEN I clinical study using its bifurcated stent, according to the principal investigator who presented the report at the EuroPCR 2008 international medical meeting on cardiovascular intervention.
The data, presented by Eberhard Grube, M.D., chief of Cardiology and Angiology at HELIOS Heart Center (Germany) and principal investigator of the OPEN I study, included safety results after 30 days post-implantation of the Stentys bifurcated stent in the first 13 patients.
